Funded Startups in New Haven
Among the 27 most recent funded entries for New Haven, the disclosed amounts show a clear upper tail: VeraDermics raised $150M on 2025-10-13, which dwarfs…
Among the 27 most recent funded entries for New Haven, the disclosed amounts show a clear upper tail: VeraDermics raised $150M on 2025-10-13, which dwarfs the next-largest disclosed rounds (e.g., Biohaven Pharmaceutical at $302M is actually larger, but Biorez and others sit below $30M; among all disclosed amounts, the $302M round is the largest). Most funding activity clusters in mid/late 2024 and 2025: several rounds fall between 2024-05-01 and 2024-09-18 (including Quantum Circuits at $27M on 2024-05-01 and Oxylus Energy at $5M on 2024-09-03), while earlier entries extend back to 2020-06-25 (Simcha Therapeutics, amount undisclosed). Sector coverage is dominated by life sciences: Biotechnology appears repeatedly (e.g., Arvinas on 2025-08-15, Precipio Diagnostics on 2024-05-06, and Cybrexa Therapeutics on 2021-03-10), alongside Health Care (VeraDermics in 2025, DeepLook Medical in 2024) and a smaller set of non-health categories. Stage labeling is frequently incomplete: 9 entries are marked “Series Unknown/Undisclosed,” spanning both small checks like Floe’s $30K (2025-03-17) and large checks like Biohaven Pharmaceutical’s post-IPO equity ($302M, 2022-10-20).
Most recent rounds
27 shownRelated listings
Frequently asked
What’s the largest disclosed round among these New Haven entries, and how extreme is it versus the rest?
Biohaven Pharmaceutical’s $302M round on 2022-10-20 is the largest disclosed amount on the page, sitting well above other big disclosed checks such as VeraDermics’ $150M on 2025-10-13 and Quantum Circuits’ $27M on 2024-05-01.
Do most deals cluster into a narrow time window in the most recent list?
Yes. Several rounds concentrate in late 2024 and 2025, including Oxylus Energy ($5M, 2024-09-03), DeepLook Medical (undisclosed, 2024-09-18), and VeraDermics ($150M, 2025-10-13), while the series still reaches back to 2020-06-25 (Simcha Therapeutics).
Are “Series Unknown” or “undisclosed” amounts common, and does that affect how interpretable deal size is here?
Stage/amount visibility is limited: 9 entries are labeled “Series Unknown” or “Undisclosed/blank,” with examples including Arvinas (2025-08-15, amount undisclosed) and DeepLook Medical (2024-09-18, amount undisclosed). The mix includes both small disclosed checks (Floe at $30K, 2025-03-17) and very large disclosed rounds (Biohaven Pharmaceutical at $302M, 2022-10-20), so missing data can mask part of the distribution.
Which sectors appear most frequently, and does the list lean toward life sciences?
Biotechnology and Health Care dominate by recurrence: Biotechnology shows up across entries such as Arvinas (2025-08-15), Precipio Diagnostics (2024-05-06), and Cybrexa Therapeutics (2021-03-10), while Health Care includes VeraDermics (2025-10-13) and Revmedica (2023-06-14, $14M). Other sectors like Administrative Services, Energy, and AI appear, but with less repetition.
Any geographic outliers or city-name ambiguities within the New Haven filter?
Most rows use New Haven, Connecticut, but there is a clear location outlier: Log Still Distillery lists New Haven, Kentucky (Seed, $750K on 2024-09-04). Another cross-state anomaly appears with Allyx Therapeutics, labeled New Haven, New York (2021-06-01, $8M).
Which entries closed most recently and what does the top-end stage mix look like at the newest dates?
The most recent dated entry is VeraDermics (Series C, $150M) on 2025-10-13, followed by Arvinas (Series Unknown, amount undisclosed) on 2025-08-15. In the newest quarter, disclosed sizes range from Floe at $30K (2025-03-17) to D2B3 at $500K (2025-04-07), indicating a wide spread rather than one-size-fits-all late-period financing.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.